
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : ZIP-1642
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Charles River Laboratories, Inc
Deal Size : Undisclosed
Deal Type : Collaboration
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
Details : Ziphius Vaccines is developing a proprietary self-amplifying mRNA technology platform combined with innovative lipid formulations for delivery. saRNA or replicon RNA has the advantage of having self-replicating features.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
June 23, 2022
Lead Product(s) : ZIP-1642
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Charles River Laboratories, Inc
Deal Size : Undisclosed
Deal Type : Collaboration
